Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Dec 22;15(1):51. doi: 10.3390/nu15010051

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Effects of BB68S intervention on the composition of the gut microbiota. (A) Relative abundances of main phyla between groups. (B) Relative abundances of main genera ≥1% between groups. (C) Significantly different genera levels after intervention in the BB68S group. (D) Significantly different genera levels between 2 groups after intervention. (E) LEfSe analysis indicated significant differences between the 2 groups after intervention. * p ≤ 0.05. Placebo_V0: samples of the placebo group at baseline, Probiotic_V0: samples of the probiotic group at baseline, Placebo_V1: samples of the placebo group after intervention, Probiotic_V1: samples of the BB68S group after intervention.

Effects of BB68S intervention on the composition of the gut microbiota. (A) Relative abundances of main phyla between groups. (B) Relative abundances of main genera ≥1% between groups. (C) Significantly different genera levels after intervention in the BB68S group. (D) Significantly different genera levels between 2 groups after intervention. (E) LEfSe analysis indicated significant differences between the 2 groups after intervention. * p ≤ 0.05. Placebo_V0: samples of the placebo group at baseline, Probiotic_V0: samples of the probiotic group at baseline, Placebo_V1: samples of the placebo group after intervention, Probiotic_V1: samples of the BB68S group after intervention.